Cells in response to treatment with mifepristone concentrations of 1 and 5 μM showed similar or higher levels of phosphorylated Akt T308 or S473, when compared to control cultures at one of the time points, resulting in ineffective inhibition of the Akt signalling pathway in the oral cancer cells. This evidence concerns the gene AKT1 and lip and oral cavity carcinoma.